Beta Bionics, Senseonics Partner to Integrate Diabetes Devices

08:07 AM EDT, 09/22/2026 (MT Newswires) -- Beta Bionics (BBNX) said Tuesday it partnered with Senseonics (SENS) to integrate its iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics' Eversense 365 continuous glucose monitor. The company said the integrated iLet and Eversense 365 system is expected to launch commercially in Q4. Beta Bionics said the integration will give iLet users access to more continuous glucose monitoring options. The companies also plan to integrate the mint system with Eversense 365 in the future, the company added.